Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Classement en actions #39464
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Prix de l'action
$0.11725176
Dernière synchronisation: 2025-07-14
Capitalisation boursière
$481.50K
Changement (1 jour)
-0.20%
Changement (1 an)
0.00%
Pays
FR
Échange PHAXIAM Therapeutics S.A. (PHXM)

Catégorie

Historique du prix de l'action pour PHAXIAM Therapeutics S.A. (PHXM)
Prix de clôture le plus élevé : $0.12 le 2025-07-01

Prix de clôture le plus bas : $130.13 le 2013-05-01
Historique du prix de l'action de PHAXIAM Therapeutics S.A. de 2013 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -93.43%
2024 -61.15%
2023 -4.10%
2022 -78.67%
2021 -73.09%
2020 82.18%
2019 -31.14%
2018 -67.04%
2017 59.44%
2016 -51.03%
2015 -15.90%
2014 158.90%
2013 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 32.51%
US
$857.76 31.47%
NL
$733.78 7.43%
CH
$1.07K -6.40%
KR
$260.01 14.86%
BE